Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease

Mauro Mastronardi, Margherita Curlo, Elisabetta Cavalcanti, Osvaldo Burattini, Renato Cuppone, Romina Tauro, Stefania De Santis, Grazia Serino, Pasqua Letizia Pesole, Elisa Stasi, Maria Lucia Caruso, Rossella Donghia, Vito Guerra, Pietro Giorgio, Marcello Chieppa

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences